Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, July 2001, p. 724-730, Vol. 8, No. 4
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.4.724-730.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Standardized Method of Measuring
Acanthamoeba Antibodies in Sera from Healthy Human
Subjects
Cynthia L.
Chappell,1,*
John A.
Wright,1
Michael
Coletta,1,
and
Anthony L.
Newsome2
Center for Infectious Diseases, School of
Public Health, University of Texas Health Science Center at Houston,
Houston, Texas1 and Department of
Biology, Middle Tennessee State University, Murfreesboro,
Tennessee2
Received 27 November 2000/Returned for modification 2 March
2001/Accepted 27 March 2001
 |
ABSTRACT |
Acanthamoeba species can cause serious, debilitating,
and sometimes life-threatening infections. Three groups have been
identified using morphological and immunological comparisons. Previous
serological studies have utilized a variety of antigen preparations and
assay methods and reported disparate (3 to 100%) results. This study was designed to (i) optimize an enzyme-linked immunosorbent assay for
detecting serum antibodies to each of the Acanthamoeba
serogroups and (ii) test 55 healthy individuals for specific
immunoglobulin G reactivity. The highest signal-to-background ratio was
found when 3,000 fixed, intact trophozoites per well were used with a
1:10 serum dilution. Sera yielding optical densities of <0.25 against
all three Acanthamoeba serogroups were used to define the
cutoff for positive results. The highest background reactivity with
these sera was seen with Acanthamoeba polyphaga (serogroup 2), followed by Acanthamoeba culbertsoni (serogroup 3) and
Acanthamoeba astronyxis (serogroup 1). Of 55 subjects
tested, the highest number of positive results was seen with A. polyphaga (81.8%), followed by A. astronyxis
(52.8%) and A. culbertsoni (40%). Seven serum samples
(12.7%) were negative for all three Acanthamoeba
serogroups, 16 (29.1%) were positive for one serogroup only, 16 were
positive for two serogroups, and 16 reacted to all three serogroups.
Further analysis showed no significant associations between serogroup reactivity and age or gender. However, some ethnic differences were
noted, especially with A. polyphaga antigens. In that case, serum samples from Hispanic subjects were 14.5 times less likely to be
positive (P = 0.0025) and had lower mean absorbance
values (P = 0.047) than those from Caucasian subjects.
Overall, these data suggest that Acanthamoeba colonization
or infection is more common than previously thought. Mild or
asymptomatic infections may contribute to the observed serum reactivities.
 |
INTRODUCTION |
Acanthamoebae are free-living
protozoans found in the soil worldwide. Infection with
Acanthamoeba spp. can cause serious disease with high
morbidity and/or mortality (20). Central nervous system (CNS) infection is uniformly fatal within weeks to months. The organism
appears to have a relatively low virulence, as evidenced by the rarity
of the infection, and it is an opportunist in individuals compromised
by human immunodeficiency virus infection, diabetes, immunosuppressive
therapy, malignancies, malnutrition, or chronic alcoholism
(19). In comparison, Acanthamoeba keratitis
does not typically lead to CNS infection but has very significant
morbidity, often requiring one or more successive corneal transplants
or complete enucleation (16). Contact lens wearers are at
higher risk of infection, especially where microabrasions are present (11). Skin infections have also been documented and may
serve as the nidus for a hematogenous spread to the CNS
(17). Likewise, Acanthamoeba has been found
within alveoli of compromised patients with pneumonitis
(18) and has been recovered from nasal and pharyngeal
swabs from immunocompetent, asymptomatic individuals (1, 3, 15,
28); the latter suggests that transient respiratory infections
may occur.
Taxonomic relationships among Acanthamoeba species are
currently based on morphological and serological evidence (22,
27) and suggest the existence of three distinct groups.
Morphological differences based on the cyst stage have been confirmed
by immunological studies. Antibodies specific to trophozoites from
various Acanthamoeba species have been generated and
cross-tested. These data show high reactivity within a morphological
group, but little to no reactivity between groups. Specifically, groups
2 and 3 show minor cross-reactivity, but neither shows cross-reactivity
with group 1. These findings suggest that each Acanthamoeba
group displays a unique set of antigens and would elicit a
group-specific antibody in infected hosts, including humans. The
ubiquitousness of the organism in soil and surface waters suggests that
all humans are exposed to this potential pathogen. Further, mild or
subclinical infections (skin or respiratory infections) may be
self-limited and not diagnosed. If such infections occur, immune
stimulation, including a serum antibody response, presumably ensues and
should be detectable. Therefore, the finding of serum antibodies
specific to Acanthamoeba would suggest previous exposure
and/or colonization by this organism. Serum antibodies have been found
in individuals with systemic Acanthamoeba infections
(13) and in some patients with keratitis (7,
26).
Population studies of serum antibodies to Acanthamoeba are
few in number (2, 6) and contradictory in their findings. Cursons et al. (6) studied sera from 80 persons from three New Zealand health clinics. Immunoglobulin reactivities in indirect fluorescence antibody assays using Acanthamoeba castellanii
(serogroup 2) and Acanthamoeba culbertsoni (serogroup 3)
trophozoites were judged to be uniformly positive, with titers of 1:20
or 1:40, respectively, although no definition of a positive reaction
was provided. In another study (2), sera from 1,054 individuals were tested against A. culbertsoni using an
indirect hemagglutination assay. Titers of 1:40 were considered
positive. A positive reaction was found in 3.2 to 3.3% of 282 healthy
individuals and 274 psychiatric patients. A higher seroprevalence was
seen in 448 hospitalized patients (9.1% positive), especially among 94 diagnosed with liver and gall bladder diseases (17% positive). In
response to this observation, 50 individuals from a hepatitis A
outbreak were studied, and 52% were positive.
Neither of the seroprevalence studies provided methodological details
or information on the definition of a positive result. Also, comparison
of these studies is complicated by the fact that two different methods,
indirect hemagglutination and indirect fluorescence antibody assays,
were employed. The purposes of the present study were (i) to develop a
well-characterized enzyme-linked immunosorbent assay (ELISA) for
detecting serum antibodies to Acanthamoeba, (ii) to compare
the immunoglobulin G (IgG) reactivities among representative species
from each of the three Acanthamoeba serogroups, (iii) to
define a negative population and cutoff values for a positive reaction,
and (iv) to report the range of IgG reactivity in a healthy population.
 |
MATERIALS AND METHODS |
Study population.
Fifty-five healthy adults were
recruited as part of an ongoing, unrelated study at the University of
Texas School of Public Health (4, 8, 24) (Table
1). The study was approved by the
Committee for the Protection of Human Subjects at the University of
Texas Health Science Center at Houston. These 55 individuals were in
excellent general health, with no previous episodes of encephalitis,
keratitis, or serious soft tissue infection. Study subjects had a
median age of 28.4 years (mean, 30.7 years; range, 19 to 51 years).
Females made up 56.4% of the population. Four ethnic groups were
represented, with the majority (58.2%) being Caucasian.
Serum collection.
After informed consent was obtained, blood
was collected from volunteers, and serum was separated, aliquoted, and
frozen at
86°C prior to use. Specimens were obtained from March
1992 to March 1999.
Antigen for developing hyperimmune antisera was prepared by adjusting
amoebae to 2 × 105 cells per ml in 0.15 M
phosphate-buffered saline (PBS) pH 7.2, and then subjecting them to
four freeze-thaw cycles with liquid nitrogen. New Zealand White rabbits
(weight, 2 kg) were immunized via the marginal ear vein weekly with 2 ml of the antigen preparation for a total of 4 weeks. One week after
the final immunization, rabbits were bled and sera were collected.
Negative-control sera were drawn from rabbits prior to inoculation with
amoebae. These experiments were carried out previously by one of the
authors (A.L.N.) at the Indiana University School of Medicine
(Indianapolis). Sera were sent to Houston on dry ice and stored at
86°C before use.
Growth of Acanthamoeba trophozoites and ELISA antigen
preparation.
Acanthamoeba astronyxis cultures were
obtained from the American Type Culture Collection (ATCC 30137), and
Acanthamoeba polyphaga was transferred to Houston from the
laboratory of one of the authors (A.L.N.). The A. culbertsoni culture was a gift from Gene Siders (Indiana
University). All of the amoeba species were grown in 15-ml conical
tubes containing peptone-yeast extract-glucose medium (PYG)
supplemented with 5% heat-inactivated fetal bovine serum plus minimal
essential medium (MEM) vitamin mixture (1:2 dilution; Life
Technologies-Gibco BRL, Rockville, Md.). Tubes containing A. astronyxis and A. polyphaga were incubated at room
temperature, while A. culbertsoni required 37°C for
optimal growth. All cultures were grown for 7 to 10 days before being
transferred to 75-cm2 tissue culture flasks. Flasks were
incubated under the same conditions, and trophozoites were harvested
when they grew to 80 to 100% confluency.
To induce rounding and release of the amoebae into the medium, medium
in flasks containing adherent trophozoites was replaced with 50 ml of
0.15 M PBS, pH 7.6, and placed in an ice bath for 30 min. The cell
suspension was centrifuged at 2,500 × g for 10 min,
and the pellet was resuspended in 10 ml of PBS containing 1% formalin.
Fixed amoebae were stored at 4°C for as long as 1 week. Prior to use,
fixed amoebae were washed three times in PBS as above and then
resuspended in 10 ml of PBS, and aliquots were counted on a
hemacytometer. Amoebae were then diluted (1:7 to 1:20) in 0.05 M sodium
carbonate buffer, pH 9.6, to achieve the desired concentration for
coating of microtiter wells.
In one set of experiments, a known number of fixed trophozoites were
washed free of formalin and resuspended in carbonate buffer before
being disrupted by homogenization (20 s; Tissue Tearor; Biospec
Products, Inc., Bartlesville, Okla.) and sonication (60 Sonic
Dismembrator; Fisher Scientific, Pittsburgh, Pa.) for 15 s. This
resulted in complete disruption of the amoebae as assessed by
microscopy. The trophozoite extract was used immediately.
ELISA procedure.
The ELISA method used in these studies was
adapted from the work of Sheets et al. (25). A known
number of fixed amoebae (or antigens from the same number of disrupted
amoebae) were placed in microtiter wells and incubated at 37°C for
1 h, followed by overnight incubation at 4°C. Plates were washed
three times with 0.15 M PBS, pH 7.2, containing 0.1% Tween 20, between
each incubation step. Wells were blocked for 90 min at 37°C with 200 µl of 5% dry milk-PBS. Human sera (1:10 in 100 µl) were then added
to wells and incubated at 37°C for 1 h. This was followed by the
addition of horseradish peroxidase (HRP)-conjugated goat anti-human IgG (1:1,000; Zymed Laboratories, Inc., South San Francisco, Calif.). For
some experiments where rabbit sera were used, conjugate consisted of
HRP-conjugated anti-rabbit IgG (ICN Biomedical, Aurora, Ohio). Reactions were visualized by the addition of peroxidase-activated (final concentration, 0.03%)
2,2'-azino-di-[3-ethylbenzthiazolinesulfonate(6)] (Boehringer Mannheim, Indianapolis, Ind.). Plates were read
spectrophotometrically (TiterTek Multiskan MCC/340 ELISA Reader; Flow
Laboratories, McLean, Va.) at 414 nm after 3, 5, 10, 15, and 30 min.
Each plate included triplicate wells of two to three individual human
serum samples, which consistently yielded low absorbance values
(
0.300; negative sera) or high absorbance values (>1.0; positive
sera), and other wells, which contained all reagents except primary
serum (reagent control). All unknown sera were tested in duplicate.
Data were expressed as net absorbance, calculated by subtracting the
mean absorbance of the reagent control wells from the mean absorbance of the specimen wells.
Statistical evaluation.
Fifty-five sera were tested against
each of the amoeba serogroups, and the absorbance values of all 55, as
well as the absorbances of the nonresponder subset (n = 7), were compared using a one-way analysis of variance (ANOVA) and
a Tukey-Kramer multiple comparisons test. ANOVA was also used to
compare age and ethnic groups. To test for potential cross-reactivity
among the three Acanthamoeba serogroups, the data were
subjected to McNemar's test for correlated proportions. Ethnic groups
tested against A. culbertsoni were compared using the
Kruskal-Wallis test because the data were non-Gaussian. Mean
absorbances of gender groups were analyzed with Student's t
test (unpaired). Other categorical data were compared using a
chi-square test or Fisher's exact test. In all analyses, a
P value of <0.05 was considered significant.
 |
RESULTS |
Selection of antigen concentration.
A checkerboard
pattern utilizing twofold serial dilutions of fixed A. polyphaga trophozoites (24 to 50,000 trophozoites) and rabbit
anti-A. polyphaga serum (1:100 to 1:12,800) was reacted to
establish the optimal antigen concentration. Preimmune rabbit serum was
tested in the same fashion on a separate plate. All dilutions of the
hyperimmune serum showed high reactivity to the trophozoites (data not
shown); however, a serum dilution of 1:400 was chosen to establish the
optimal antigen concentration (Fig. 1).
High reactivity (optical density [OD], >1.5) was seen at
concentrations of 1,563 to 50,000 trophozoites, and reactivity
decreased in a linear fashion to 195 trophozoites per well. Lower
trophozoite concentrations (down to 24/well) yielded OD readings near
background levels. In comparison, negative-control serum showed high
reactivity (OD, 0.7) in wells containing 50,000 trophozoites, but
reactivity decreased linearly with trophozoite concentrations down to
approximately 6,250. At lower concentrations, absorbance values
plateaued at an OD of approximately 0.1 to 0.2. From these data, an
amoeba concentration of approximately 3,000/well was chosen as optimal for subsequent experiments, since that number yielded the highest signal-to-background ratio.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Net absorbances (IgG) of rabbit sera in wells containing
different numbers of A. polyphaga trophozoites. Sera from a
rabbit immunized with A. polyphaga (solid circles) and an
unimmunized rabbit (open circles) were tested at a 1:400 dilution.
|
|
In a separate experiment, we compared the antibody reactivity to intact
versus disrupted A. polyphaga trophozoites. Each well contained the equivalent of 3,000 trophozoites, whether intact or
disrupted. Six sera showing low (OD, <0.2) to high (OD, >0.6) reactivity against intact, fixed trophozoites were used in the assays.
Each of the sera showed higher absorbance values when incubated with
the disrupted compared to the intact trophozoites (data not shown),
with an overall mean increase in OD of 2.2-fold. Thus, sera showing low
absorbances against intact trophozoites had significantly higher
absorbances when an equivalent number of disrupted trophozoites were
used, which led to false-positive results. These data indicate that
cytosolic antigens may contribute to nonspecific reactivity and a high
estimation of seroprevalence. This would be most problematic in
Acanthamoeba serogroups which yield a relatively low
seroprevalence when intact trophozoites are used. In these cases,
cytosolic antigens would likely increase the absorbance values above
the cutoff for positivity and cause serious overestimation of the seroprevalence.
Definition of positive results.
Sera from six individuals were
tested at a dilution of 1:10 against A. polyphaga
trophozoites in order to examine their relative reactivities (data not
shown). Two sera yielding high or low absorbance values were selected
for titration (Fig. 2). In this
experiment, twofold serial dilutions (1:10 to 1:1,280) of the sera were
tested. With the highly reactive serum, dilutions of 1:10 and 1:20
yielded similar absorbance values (ODs of 1.4 or higher). Dilutions
between 1:40 and 1:160 were essentially linear in OD, but declined more slowly thereafter until "background" levels were reached at
1:1,280. In comparison, the low-reactivity serum showed only a slight
decline in absorbance value from 1:10 to 1:80 and remained relatively stable thereafter. No prozone effect was observed with either serum.
Based on the high signal-to-background ratio, a serum dilution of 1:10
was chosen for all subsequent experiments.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Net absorbance of IgG from healthy humans to A. polyphaga trophozoites. Sera from a responder (solid circles) and
a nonresponder (open circles) were tested against 3,000 trophozoites
per well. Each point represents the mean ± SD of triplicate
assays.
|
|
Since a known unexposed population could not be determined, background
reactivity (i.e., negative control) had to be empirically defined. All
55 human serum samples were tested against three Acanthamoeba species representing the three serogroups.
Persons whose serum samples had low absorbance values (OD, <0.25) with all three serogroups were considered nonreactive; seven individuals fell into this group. The mean absorbance values and standard deviations (SD) for each serogroup are shown (Fig.
3). Serogroups 1 (A. astronyxis) and 3 (A. culbertsoni) yielded mean
absorbance values in the same range (0.126 and 0.143, respectively),
while serogroup 2 (A. polyphaga) yielded a mean absorbance
of 0.204, which was significantly higher (P < 0.02)
than those with the other serogroups. These mean absorbance values and
SD were used to estimate the antibody reactivities of the remaining 48 serum samples. Positive reactions were defined as any absorbance value that exceeded 3 SD above the mean for each serogroup and cutoff values
were as follows: for serogroup 1, >0.288; for serogroup 2, >0.255;
for serogroup 3, >0.172.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
Mean absorbance values of nonresponders to each of the
three Acanthamoeba serogroups. Each value is the mean ± SD for seven healthy individuals tested against serogroup 1 (A. astronyxis), serogroup 2 (A. polyphaga), or
serogroup 3 (A. culbertsoni) antigens. Serum IgG from each
individual was tested in triplicate against each serogroup by ELISA.
|
|
Reproducibility of results.
Serum samples yielding low to
moderate absorbance values were evaluated for assay variability because
these lower values were expected to show a greater coefficient of
variation (CV) than higher absorbance values. Each serum sample was
tested in duplicate against each of the three serogroups. Two serum
samples incubated with A. astronyxis and four serum samples
incubated with A. polyphaga showed similar well-to-well
variabilities in absorbance, with CVs in the range of 0.11 to 0.14 and
0.06 to 0.14, respectively. One serum sample tested with A. culbertsoni had a well-to-well variation of 29%. In addition,
plate-to-plate variation of the same serum samples ranged from 8 to
26% among amoeba species. These data suggest that the results within
and between plates were repeatable; however, it is prudent to include
negative-control sera on each plate in order to standardize results.
Reactivity to Acanthamoeba serogroups.
All 55 serum samples were tested for IgG reactivity to each of the
Acanthamoeba serogroups, and the frequency distributions of
net absorbances were calculated (Fig. 4).
Serogroup 1 reactivities ranged from absorbances of 0.068 to 0.806, with a median value of 0.300. In comparison, serogroups 2 and 3 yielded
absorbances from 0.184 to 0.707 (median, 0.333) and 0.071 to 0.392 (median, 0.156), respectively. Overall absorbance values with A. culbertsoni were significantly lower than those with the other two
Acanthamoeba species (P = 0.0001).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Frequency distribution of net absorbances of IgG from 55 healthy subjects in response to Acanthamoeba serogroup
antigens. Each serum was tested at a 1:10 dilution in duplicate wells
against serogroup 1 (A), serogroup 2 (B), or serogroup 3 (C)
trophozoites.
|
|
Based on the defined cutoff value (mean + 3 SD) for each
serogroup, the percent positive sera was calculated. Percent antibody reactivity was high in each serogroup: for serogroup 1, 52.8%; for
serogroup 2, 81.8%; for serogroup 3, 40.0%. These data indicate that
colonization or mild infection with Acanthamoeba may be a relatively common occurrence. Analysis of the difference in proportions revealed significant differences between serogroup 2 and serogroup 1 (P = 0.004) or serogroup 3 (P = 0.0001)
but no difference between serogroups 1 and 3 (P = 0.130). Thus, A. polyphaga yielded the highest
background absorbances (Fig. 3), the highest overall absorbance values
(Fig. 4), and the highest percent positive reactivities compared to the
other two amoeba species. In contrast, A. culbertsoni yielded low background absorbance values, the lowest overall
absorbances, and the lowest percent positive reactivities. These
results suggest that among the three Acanthamoeba species
studied A. polyphaga is most commonly and A. culbertsoni is the least commonly encountered by the healthy population.
A table of positive or negative reactivity for each of the 55 serum
samples tested against each serogroup was prepared (data not shown).
All possible combinations of reactivity to each amoeba species were
analyzed (Table 2). Forty-eight (87.3%)
individuals were positive for one or more serogroups. Of these, equal
numbers (i.e., 16 subjects) were positive for one serogroup only, two serogroups, or all three serogroups. Thirteen (81.2%) of the 16 subjects who were positive for one serogroup only had serum samples that reacted against A. polyphaga.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
IgG reactivities of serum samples of 55 healthy adults to
Acanthamoeba species representing each serogroup
|
|
Potential cross-reactivity among serogroups was assessed by examining
the number of individuals whose serum samples were reactive to any one
of the serogroups alone. Two samples were positive for serogroup 1 (A. astronyxis) alone, 13 for serogroup 2 (A. polyphaga) alone, and 1 for serogroup 3 (A. culbertsoni) alone. If significant cross-reactivity were
occurring, one would expect that the A. polyphaga positive
serum samples would also be positive for the other serogroups. Since
this was not the case, we conclude that the antibody response to each
serogroup appears to be independent. We further subjected the data to
statistical analysis (McNemar's test for correlated proportions) and
found that antibody reactivities against the three serogroup antigens
were independent.
Potential risk factors for antibody reactivity to
Acanthamoeba species.
Age, gender, and ethnic data
were available for all 55 study subjects. Comparisons of percent
positive serum samples (for each serogroup) were made among all four
age groups (see Table 1). No significant differences or trends were
found to suggest an increased (or decreased) antibody reactivity in
older age groups (data not shown). Further, comparison of absorbance
values confirmed a lack of association between age and reactivity to
Acanthamoeba antigens. In a similar manner, gender was
assessed as a factor in antibody reactivity to Acanthamoeba
serogroups. No significant differences were seen between males and
females when the number of positive serum samples or the absorbance
values were compared.
Four ethnic groups were represented in the study population; however,
low numbers of Asians prevented a complete analysis. The percent
positive serum samples in each ethnic group and the mean absorbance
values for each ethnic group were compared among the three
Acanthamoeba serogroups. When serum samples were tested against serogroup 1 antigens, the percent positive samples was >65%
for Caucasians (n = 32) and Asians (n = 3) versus 40% for Hispanics (n = 10) and 20% for
African-Americans (n = 10). In this analysis, the
percent positive Caucasians was significantly higher than the percent
positive African-Americans (P = 0.026; odds ratio
[OR] = 7.6; 95% confidence interval [CI] = 1.4 to 42.4). For
serogroup 2 antigens, Caucasians, African-Americans, and Asians were
each
90% positive compared with 40% positive Hispanics
(n = 10); however, the only difference that reached
statistical significance was that between Caucasians and Hispanics
(P = 0.0025; OR = 14.5; 95% CI = 2.6 to
82.3). The latter difference was also seen when A. polyphaga
absorbance values from Caucasians and Hispanics were compared
(P = 0.047) (Fig. 5). No
other significant associations were seen among the ethnic groups
regardless of the Acanthamoeba serogroup which was examined.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Mean (and SD) absorbance values for serum samples of
various ethnic groups tested against each Acanthamoeba
serogroup. Ethnic groups are shown in the following order: Caucasian
( ), African-American ( ), Hispanic ( ), and Asian ( ). The
asterisk indicates a statistically significant difference (P < 0.05) between Caucasians and Hispanics.
|
|
In addition, subjects whose serum samples reacted to no serogroup or to
one, two, or all three serogroups were compared with regard to age,
gender, and ethnic origin. No significant associations were found
between gender or age and reactivity to these serogroups. When
ethnicity was analyzed, it was noted that the serum samples of 75% of
Caucasians and 100% of Asians were positive for two or three
serogroups, compared with 30% for African-Americans and 20% for
Hispanics. Since the number of individuals in each ethnic group was
limited, the groups with high percentages of positive samples
(Caucasians and Asians) were combined, and those with low percentages
of positive samples (African-Americans and Hispanics) were combined.
Analysis indicated a significant difference (P = 0.0013), with Caucasians and Asians being 7.8 (95% CI, 2.2 to 28)
times more likely to be positive for two or three serogroups than
African-Americans and Hispanics. The results were similar (P = 0.0051; OR = 5.6; 95% CI = 1.7 to 18.2) when
Caucasians were compared to all other ethnic groups combined.
 |
DISCUSSION |
An ELISA method has been optimized for detecting
anti-Acanthamoeba IgG in human serum samples. The method
utilizes whole, fixed trophozoites rather than disrupted trophozoites,
which gave higher background reactivity. This suggests that cytosolic
antigens from the amoebae can contribute to nonspecific binding and/or cross-reactivity that would obfuscate interpretation of results. The
method has been optimized for antigen and serum concentrations; 3,000 trophozoites per well and a serum dilution of 1:10 were found to yield
the highest signal-to-background ratios. Since the ubiquitousness of
the amoeba precludes an easy definition of an unexposed negative
population, an empirical definition was required. For this, serum
samples with low absorbance values (OD,
0.250) in response to all of
the serogroups were chosen to represent nonreactive (negative-control)
serum samples. Cutoff values (mean + 3 SD) for each serogroup were
then calculated from the mean and SD of these absorbances. Inclusion of
negative-control serum samples and a reagent control on each plate
ensured standardized results.
Two early studies examining different populations report conflicting
results, one with seroprevalences in the 3% range (2) and
another with seroprevalences at 100% (6). In each of
these studies, A. culbertsoni was used as the antigen in an
indirect hemagglutination or indirect fluorescence antibody format.
Interestingly, in one of these studies (6) the amoebae
used in the antigen preparation were grown on agar seeded with
Enterobacter cloacae, which could have contributed to the
100% reactivity reported. Neither report described the antigen
preparation in detail or provided a rationale for its definition of
positive reactivity. It is also of interest that the antibody titers
reported in both studies were all in the range of 1:20 to 1:40;
however, differences in what was considered negative led to essentially
opposite interpretations. A recent publication examines a leptomyxid
amoeba, Balamuthia mandrillaris, a species also known to
cause granulomatous amoebic encephalitis (12). Whole,
fixed trophozoites were used in an indirect fluorescence antibody
assay, and results were confirmed by flow cytometry; however, no
negative-control serum samples were described. This paper demonstrated
that all 50 children and adults tested had anti-amoeba serum antibody
titers (IgM and IgG) in the range of 1:64 to 1:256. This response was
shown to be non-cross-reactive with Acanthamoeba or
Naegleria.
In comparison to the earlier reports, the present study uses
well-characterized parameters in the testing procedure and has taken a
detailed approach to defining negative and positive results. A. culbertsoni, also used in the earlier studies, gave the lowest overall absorbances and the lowest percent seropositive results (39.3%) compared to the other two amoeba species. The highest overall
absorbances and the highest seropositivity (81.8%) were seen with
A. polyphaga.
The relative occurrence of Acanthamoeba species in soil
and/or surface water has not been thoroughly studied, but the species associated with human Acanthamoeba infections are thought to
be representative of amoebic species in the environment. Additional data on Acanthamoeba species distribution in the environment
will be necessary to confirm this notion and to further examine the effects of geographic locations (tropical to temperate zones), seasons,
rainfall, and other factors influencing amoeba growth. However, if we
are to accept the current belief that group 2 species (including
A. polyphaga) are the most common in the environment (27) and group 3 species (including A. culbertsoni) are the least common (21), then our
findings are consistent. According to this view, we might then predict
from our data that A. culbertsoni and the group 3 species
are the least common in the environment. Thus, it appears that the
differences seen in the reactivities of serum samples of healthy
persons to the various serogroups may reflect the relative exposure of
the population to these species in addition to virulence differences.
However, additional studies on this point are needed.
When serological studies are undertaken, the potential for
cross-reactivity is always a concern. While we found no evidence of
cross-reactivity among the three Acanthamoeba serogroups, we did not test for reactivity toward other amoebae that are known to
cause human infections. Earlier studies examining cross-reactivity between Acanthamoeba and Naegleria
(10) or Balamuthia (11) found
none. Nevertheless, the potential for cross-reactivity needs to be
further studied but will require antisera produced in animals that are
strictly raised so as to prevent any inadvertent exposure to
Acanthamoeba in dirt or water.
It is clear from the data presented here that the interpretations of
serological studies are heavily influenced by the
Acanthamoeba species used as the antigen. Since
80% of
tested individuals had antibodies to A. polyphaga, it is
unlikely that a "high risk" group would show any significant
increase in seroprevalence. Thus, for epidemiological studies of
healthy versus other populations, serogroup 1 and/or 3 antigens would
likely be more useful. The recognition that transient infections with
Acanthamoeba are possible could open new avenues for
epidemiological studies. Recently, a number of reports have linked
human bacterial pathogens, such as Legionella
(23), Chlamydia (9), and
Mycobacterium (5, 14) spp., to
Acanthamoeba. These bacteria are able to survive phagocytosis and replicate in amoebic vacuoles. Further, the
Acanthamoeba vector appears to maintain or even enhance the
virulence of these bacteria (5). Such observations suggest
that Acanthamoeba may play an important role in the survival
of bacterial pathogens in the environment and may serve as a mode of
transmission, perhaps through aerosols or other mechanisms. If this is
indeed the case, then Acanthamoeba antibodies could be
detectable in individuals who have had bacterial pathogens transmitted
in this way. Selected patient populations are currently being examined
in our laboratory for an increased prevalence of
Acanthamoeba antibodies.
The number of subjects studied can only provide a preliminary notion of
the seroprevalence of Acanthamoeba in the general population. Likewise, attempts to identify potential risk factors were
hampered by low numbers in each group. Although no significant associations were seen between Acanthamoeba antibody
reactivity and gender or age group, this may not be true of the larger
population. The data presented here suggest that the males and females
studied were equally exposed. Also, the ages of the study population
were relatively narrow and did not include children or those older than
51 years. It is possible that an association may be seen in infants and
young children as they are increasingly exposed to soil and surface
water. Interestingly, there was some indication that ethnic origin may
play a role in the number of seropositive individuals and the degree of
reactivity to A. polyphaga antigens. Taken together, the
results suggest that Caucasians have a higher percent reactivity to
serogroup 1 and 2 antigens than other ethnic groups and that they are
more likely to be positive for multiple serogroups. It is not clear
whether these findings indicate an increase in exposure, an enhanced
antibody response to amoebic antigens, or some other, unknown factor.
In summary, the data reported herein suggest that mucosal colonization
and/or transient, mild, or asymptomatic Acanthamoeba infections, perhaps of the skin or respiratory tract, are common. Previous isolation of Acanthamoeba in nasal washings,
pharyngeal swabs, and broncheoalveolar lavage support this view
(1, 3, 15, 28). Thus, while serious ocular disease and
life-threatening CNS infections are rare, mucosal infection may
contribute significantly to the large number of undiagnosed sinus
infections and pulmonary illnesses suffered each year.
 |
ACKNOWLEDGMENTS |
This work was supported by the National Institutes of Health
General Clinical Research Centers grant (M01-RR-02558) and a University
of Texas School of Public Health Excellence in Research Award (to
C.L.C.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for
Infectious Diseases, University of Texas, Houston, School of Public
Health, 1200 Herman Pressler Dr., Houston, TX 77030. Phone: (713)
500-9372. Fax: (713) 500-9364. E-mail:
cchappell{at}sph.uth.tmc.edu.
Present address: Georgia Department of Human Resources, Division of
Health Information and Policy, Atlanta, GA 30303.
 |
REFERENCES |
| 1.
|
Badenoch, P. R.,
T. R. Grimmond,
J. Cadwgan,
S. E. Deayton,
M. S. L. Essery, and B. D. Hill.
1988.
Nasal carriage of free-living amoebae.
Microb. Ecol. Health Dis.
1:209-211.
|
| 2.
|
Cerva, L.
1989.
Acanthamoeba culbertsoni and Naegleria fowleri: occurrence of antibodies in man.
J. Hyg. Epidemiol. Microbiol. Immunol.
33:99-103[Medline].
|
| 3.
|
Cerva, L.,
C. Serbus, and V. Skocil.
1973.
Isolation of limax amoebas from the nasal mucosa of man.
Folia Parasitol.
20:97-103.
|
| 4.
|
Chappell, C. L.,
P. C. Okhuysen,
C. R. Sterling, and H. L. DuPont.
1996.
Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers.
J. Infect. Dis.
173:232-236[Medline].
|
| 5.
|
Cirillo, J. D.,
S. Falkow,
L. S. Tompkins, and L. E. Bermudez.
1997.
Interaction of Mycobacterium avium with environmental amoebae enhances virulence.
Infect. Immun.
65:3759-3767[Abstract].
|
| 6.
|
Cursons, R. T. M.,
T. J. Brown,
E. A. Keys,
K. M. Moriarty, and D. Till.
1980.
Immunity to pathogenic free-living amoebae: role of humoral antibody.
Infect. Immun.
29:401-407[Abstract/Free Full Text].
|
| 7.
|
Driebe, W. T., Jr.,
G. A. Stern,
R. J. Epstein,
G. S. Visvesvara,
M. Adi, and T. Komadina.
1988.
Acanthamoeba keratitis. Potential role for topical clotrimazole in combination chemotherapy.
Arch. Ophthalmol.
106:1196-1201[Abstract].
|
| 8.
|
DuPont, H. L.,
C. L. Chappell,
C. R. Sterling,
P. C. Okhuysen,
J. B. Rose, and W. Jakubowski.
1995.
The infectivity of Cryptosporidium parvum in healthy volunteers.
N. Engl. J. Med.
30:855-859.
|
| 9.
|
Essig, A.,
M. Heinemann,
U. Simnacher, and R. Marre.
1997.
Infection of Acanthamoeba castellanii by Chlamydia pneumoniae.
Appl. Environ. Microbiol.
63:1396-1399[Abstract].
|
| 10.
|
Flores, B. M.,
C. A. Garcia,
W. E. Stamm, and B. E. Torian.
1990.
Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.
J. Clin. Microbiol.
28:1999-2005[Abstract/Free Full Text].
|
| 11.
|
Garner, A.
1993.
Pathogenesis of acanthamoebic keratitis: hypothesis based on a histological analysis of 30 cases.
Br. J. Ophthalmol.
77:366-370[Abstract/Free Full Text].
|
| 12.
|
Huang, Z. H.,
A. Ferrante, and R. F. Carter.
1999.
Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis.
J. Infect. Dis.
179:1305-1308[CrossRef][Medline].
|
| 13.
|
Kenney, M.
1971.
The micro-Kolmer complement fixation test in routine screening for soil amoeba infection.
Health Lab. Sci.
8:5-10[Medline].
|
| 14.
|
Krishna-Prashad, R. N., and S. K. Gupta.
1978.
Preliminary report on engulfment and retention of mycobacteria by trophozoites of axenically grown Acanthamoeba castellanii Douglas.
Curr. Sci.
47:245-247.
|
| 15.
|
Lawande, R. V.,
S. N. Abraham,
I. John, and L. J. Egler.
1979.
Recovery of soil amoebas from the nasal passages of children during the dusty hartmattan period in Zaria.
Am. J. Clin. Pathol.
71:201-203[Medline].
|
| 16.
|
Ma, P.,
G. S. Visvesvara,
A. J. Martinez,
F. H. Theodore,
P.-M. Daggett, and T. K. Sawyer.
1990.
Naegleria and Acanthamoeba infections: review.
Rev. Infect. Dis.
1:490-513.
|
| 17.
|
Martinez, A. J.
1980.
Is acanthamoebic encephalitis an opportunistic infection?
Neurology
30:567-574[Abstract/Free Full Text].
|
| 18.
|
Martinez, A. J.
1982.
Acanthamoebiasis and immunosuppression. Case report.
Neuropathol. Exp. Neurol.
41:548-557[Medline].
|
| 19.
|
Martinez, A. J., and G. S. Visvesvara.
1991.
Laboratory diagnosis of pathogenic free-living amoebas: Naegleria, Acanthamoeba, and Leptomyxid.
Clin. Lab. Med.
11:861-872[Medline].
|
| 20.
|
Martinez, A. J., and G. S. Visvesvara.
1997.
Free-living, amphizoic and opportunistic amebas.
Brain Pathol.
7:583-598[Medline].
|
| 21.
|
Mergeryan, H.
1991.
The prevalence of Acanthamoeba in the human environment.
Rev. Infect. Dis.
13(Suppl. 5):S390-S391.
|
| 22.
|
Moura, H.,
S. Wallace, and G. S. Visvesvara.
1992.
Acanthamoeba healyi n. sp. and the isoenzyme and immunoblot profiles of Acanthamoeba spp., groups 1 and 3.
J. Protozool.
39:573-583[Medline].
|
| 23.
|
Newsome, A. L.,
T. M. Scott,
R. E. Benson, and B. S. Fields.
1998.
Isolation of an amoeba naturally harboring a distinctive Legionella species.
Appl. Environ. Microbiol.
64:1688-1693[Abstract/Free Full Text].
|
| 24.
|
Okhuysen, P. C.,
C. L. Chappell,
J. H. Crabb,
C. R. Sterling, and H. L. DuPont.
1999.
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults.
J. Infect. Dist.
180:1275-1281[CrossRef][Medline].
|
| 25.
|
Sheets, P. B.,
A. L. Newsome, and S. D. Allen.
1992.
Detection of human serum antibodies reactive with Acanthamoeba polyphaga by use of an indirect fluorescence antibody (IFA) test, p. D-8.1-D-8.6.
In
J. J. Lee, and A. T. Soldo (ed.), Protocols in protozoology. Allen Press, Inc., Lawrence, Kans.
|
| 26.
|
Stehr-Green, J. K.,
T. M. Bailey, and G. S. Visvesvara.
1989.
The epidemiology of Acanthamoeba keratitis in the United States.
Am. J. Ophthalmol.
107:331-336[Medline].
|
| 27.
|
Visvesvara, G. S.
1991.
Classification of Acanthamoeba.
Rev. Infect. Dis.
13(Suppl. 5):S369-S372.
|
| 28.
|
Wang, S. S., and H. A. Feldman.
1967.
Isolation of Hartmanella species from human throats.
N. Engl. J. Med.
277:1174-1179.
|
Clinical and Diagnostic Laboratory Immunology, July 2001, p. 724-730, Vol. 8, No. 4
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.4.724-730.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bloch, K. C., Schuster, F. L.
(2005). Inability To Make a Premortem Diagnosis of Acanthamoeba Species Infection in a Patient with Fatal Granulomatous Amebic Encephalitis. J. Clin. Microbiol.
43: 3003-3006
[Abstract]
[Full Text]
-
Marciano-Cabral, F., Cabral, G.
(2003). Acanthamoeba spp. as Agents of Disease in Humans. Clin. Microbiol. Rev.
16: 273-307
[Abstract]
[Full Text]